Structure

Physi-Chem Properties

Molecular Weight:  654.17
Volume:  616.351
LogP:  7.117
LogD:  3.944
LogS:  -7.281
# Rotatable Bonds:  2
TPSA:  63.63
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  8
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.21
Synthetic Accessibility Score:  5.903
Fsp3:  0.333
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.875
MDCK Permeability:  2.1528347133425996e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.787
Human Intestinal Absorption (HIA):  0.014
20% Bioavailability (F20%):  0.161
30% Bioavailability (F30%):  0.881

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.296
Plasma Protein Binding (PPB):  88.39096069335938%
Volume Distribution (VD):  1.34
Pgp-substrate:  9.361848831176758%

ADMET: Metabolism

CYP1A2-inhibitor:  0.098
CYP1A2-substrate:  0.964
CYP2C19-inhibitor:  0.181
CYP2C19-substrate:  0.96
CYP2C9-inhibitor:  0.055
CYP2C9-substrate:  0.55
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.956
CYP3A4-inhibitor:  0.077
CYP3A4-substrate:  0.951

ADMET: Excretion

Clearance (CL):  7.57
Half-life (T1/2):  0.087

ADMET: Toxicity

hERG Blockers:  0.958
Human Hepatotoxicity (H-HT):  0.04
Drug-inuced Liver Injury (DILI):  0.772
AMES Toxicity:  0.068
Rat Oral Acute Toxicity:  0.458
Maximum Recommended Daily Dose:  0.995
Skin Sensitization:  0.847
Carcinogencity:  0.038
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.575

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC254581

Natural Product ID:  NPC254581
Common Name*:   FWGCIVBZBPEQOD-NSOVKSMOSA-N
IUPAC Name:   n.a.
Synonyms:   13'-Bromo-Tiliacorinine
Standard InCHIKey:  FWGCIVBZBPEQOD-NSOVKSMOSA-N
Standard InCHI:  InChI=1S/C36H35BrN2O5/c1-38-9-7-21-16-30-31-18-23(21)27(38)15-20-12-25(34(40)26(37)13-20)24-11-19(5-6-29(24)41-3)14-28-33-22(8-10-39(28)2)17-32(42-4)35(43-30)36(33)44-31/h5-6,11-13,16-18,27-28,40H,7-10,14-15H2,1-4H3/t27-,28-/m0/s1
SMILES:  CN1CCc2cc3c4cc2[C@@H]1Cc1cc(-c2cc(ccc2OC)C[C@H]2c5c(CCN2C)cc(c(c5O4)O3)OC)c(c(c1)Br)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2017492
PubChem CID:   57404336
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO941 Tiliacora triandra Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[22418278]
NPO941 Tiliacora triandra Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens IC50 = 20.0 ug.mL-1 PMID[506460]
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 6.2 ug.mL-1 PMID[506460]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 3.1 ug.mL-1 PMID[506460]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 1.5 ug.mL-1 PMID[506460]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC254581 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9278 High Similarity NPC139783
0.9278 High Similarity NPC65312
0.9222 High Similarity NPC16357
0.9222 High Similarity NPC95426
0.9222 High Similarity NPC302245
0.9121 High Similarity NPC22115
0.9121 High Similarity NPC275680
0.9027 High Similarity NPC256124
0.8956 High Similarity NPC274716
0.8956 High Similarity NPC167116
0.8956 High Similarity NPC254441
0.8901 High Similarity NPC182052
0.8901 High Similarity NPC290582
0.8901 High Similarity NPC185639
0.8901 High Similarity NPC223690
0.8901 High Similarity NPC54654
0.8901 High Similarity NPC279228
0.8901 High Similarity NPC285931
0.8901 High Similarity NPC271013
0.8901 High Similarity NPC8836
0.8901 High Similarity NPC42663
0.8901 High Similarity NPC258657
0.8901 High Similarity NPC311973
0.8901 High Similarity NPC90998
0.8901 High Similarity NPC181796
0.8901 High Similarity NPC7715
0.8901 High Similarity NPC217748
0.8901 High Similarity NPC104196
0.8901 High Similarity NPC222661
0.8901 High Similarity NPC49075
0.8901 High Similarity NPC229373
0.8901 High Similarity NPC239824
0.8901 High Similarity NPC251735
0.8901 High Similarity NPC15414
0.8901 High Similarity NPC290005
0.8901 High Similarity NPC328155
0.8865 High Similarity NPC206900
0.8859 High Similarity NPC212237
0.8859 High Similarity NPC116465
0.8846 High Similarity NPC286119
0.8798 High Similarity NPC30779
0.8778 High Similarity NPC12424
0.8778 High Similarity NPC251580
0.8778 High Similarity NPC129518
0.8778 High Similarity NPC41376
0.877 High Similarity NPC478093
0.8723 High Similarity NPC473589
0.8723 High Similarity NPC478092
0.8723 High Similarity NPC478091
0.8723 High Similarity NPC30182
0.8722 High Similarity NPC276890
0.8722 High Similarity NPC115284
0.8722 High Similarity NPC198498
0.8722 High Similarity NPC317439
0.8722 High Similarity NPC76682
0.8722 High Similarity NPC227060
0.8722 High Similarity NPC317145
0.8722 High Similarity NPC63646
0.8722 High Similarity NPC10908
0.8717 High Similarity NPC60295
0.8717 High Similarity NPC191132
0.8681 High Similarity NPC293093
0.8663 High Similarity NPC82457
0.8663 High Similarity NPC48490
0.8663 High Similarity NPC175890
0.8663 High Similarity NPC274661
0.8663 High Similarity NPC11296
0.8571 High Similarity NPC24260
0.8548 High Similarity NPC302275
0.8541 High Similarity NPC239584
0.8486 Intermediate Similarity NPC243454
0.8486 Intermediate Similarity NPC475479
0.8457 Intermediate Similarity NPC14507
0.8457 Intermediate Similarity NPC47077
0.8396 Intermediate Similarity NPC73492
0.8396 Intermediate Similarity NPC299990
0.8333 Intermediate Similarity NPC85381
0.8325 Intermediate Similarity NPC318805
0.8325 Intermediate Similarity NPC41122
0.8308 Intermediate Similarity NPC475654
0.8297 Intermediate Similarity NPC42549
0.8297 Intermediate Similarity NPC240841
0.8297 Intermediate Similarity NPC268503
0.8297 Intermediate Similarity NPC317272
0.8297 Intermediate Similarity NPC13916
0.8297 Intermediate Similarity NPC250846
0.8297 Intermediate Similarity NPC264850
0.8297 Intermediate Similarity NPC256012
0.8247 Intermediate Similarity NPC234318
0.8242 Intermediate Similarity NPC24465
0.8211 Intermediate Similarity NPC249996
0.8207 Intermediate Similarity NPC204908
0.8207 Intermediate Similarity NPC83198
0.8186 Intermediate Similarity NPC38964
0.8177 Intermediate Similarity NPC281581
0.8172 Intermediate Similarity NPC152680
0.8172 Intermediate Similarity NPC190783
0.8172 Intermediate Similarity NPC232386
0.8148 Intermediate Similarity NPC257269
0.8148 Intermediate Similarity NPC195538
0.8148 Intermediate Similarity NPC230276
0.8135 Intermediate Similarity NPC473716
0.8135 Intermediate Similarity NPC475597
0.8132 Intermediate Similarity NPC80759
0.8132 Intermediate Similarity NPC79402
0.8118 Intermediate Similarity NPC239775
0.8111 Intermediate Similarity NPC247639
0.8111 Intermediate Similarity NPC25084
0.8105 Intermediate Similarity NPC476202
0.8095 Intermediate Similarity NPC119068
0.8095 Intermediate Similarity NPC40496
0.8077 Intermediate Similarity NPC205255
0.8077 Intermediate Similarity NPC235143
0.8077 Intermediate Similarity NPC271388
0.8077 Intermediate Similarity NPC119649
0.8077 Intermediate Similarity NPC230956
0.8065 Intermediate Similarity NPC118274
0.8065 Intermediate Similarity NPC168753
0.8022 Intermediate Similarity NPC221864
0.8021 Intermediate Similarity NPC475215
0.8021 Intermediate Similarity NPC108434
0.8019 Intermediate Similarity NPC82056
0.7957 Intermediate Similarity NPC474931
0.7957 Intermediate Similarity NPC145832
0.7957 Intermediate Similarity NPC12053
0.7957 Intermediate Similarity NPC158376
0.7957 Intermediate Similarity NPC306555
0.7957 Intermediate Similarity NPC81218
0.7957 Intermediate Similarity NPC205421
0.7957 Intermediate Similarity NPC117188
0.7935 Intermediate Similarity NPC60186
0.7926 Intermediate Similarity NPC10871
0.7906 Intermediate Similarity NPC474507
0.7895 Intermediate Similarity NPC241704
0.7892 Intermediate Similarity NPC475393
0.7857 Intermediate Similarity NPC189266
0.7857 Intermediate Similarity NPC110416
0.7857 Intermediate Similarity NPC2413
0.7857 Intermediate Similarity NPC207757
0.7857 Intermediate Similarity NPC184026
0.7857 Intermediate Similarity NPC204828
0.7857 Intermediate Similarity NPC39701
0.7857 Intermediate Similarity NPC276588
0.7857 Intermediate Similarity NPC54379
0.7857 Intermediate Similarity NPC193949
0.7857 Intermediate Similarity NPC249797
0.7857 Intermediate Similarity NPC5238
0.7857 Intermediate Similarity NPC127674
0.7857 Intermediate Similarity NPC123323
0.7857 Intermediate Similarity NPC295691
0.7857 Intermediate Similarity NPC469817
0.7857 Intermediate Similarity NPC278799
0.7857 Intermediate Similarity NPC172765
0.7849 Intermediate Similarity NPC477563
0.7849 Intermediate Similarity NPC13504
0.7849 Intermediate Similarity NPC78222
0.7849 Intermediate Similarity NPC306843
0.7849 Intermediate Similarity NPC196447
0.7849 Intermediate Similarity NPC253043
0.7849 Intermediate Similarity NPC136508
0.7849 Intermediate Similarity NPC96603
0.7849 Intermediate Similarity NPC212794
0.7812 Intermediate Similarity NPC32154
0.7807 Intermediate Similarity NPC56887
0.7807 Intermediate Similarity NPC193853
0.7807 Intermediate Similarity NPC223077
0.7801 Intermediate Similarity NPC148709
0.7801 Intermediate Similarity NPC476577
0.7801 Intermediate Similarity NPC173416
0.7796 Intermediate Similarity NPC324144
0.7796 Intermediate Similarity NPC1229
0.7772 Intermediate Similarity NPC476572
0.7754 Intermediate Similarity NPC169743
0.7754 Intermediate Similarity NPC209377
0.7727 Intermediate Similarity NPC476565
0.7704 Intermediate Similarity NPC57036
0.7696 Intermediate Similarity NPC192135
0.7696 Intermediate Similarity NPC66341
0.7696 Intermediate Similarity NPC477020
0.7688 Intermediate Similarity NPC27410
0.7688 Intermediate Similarity NPC166014
0.7684 Intermediate Similarity NPC109925
0.7677 Intermediate Similarity NPC259350
0.7677 Intermediate Similarity NPC223236
0.7672 Intermediate Similarity NPC204947
0.7668 Intermediate Similarity NPC320223
0.7668 Intermediate Similarity NPC114364
0.7667 Intermediate Similarity NPC476151
0.7667 Intermediate Similarity NPC476144
0.7667 Intermediate Similarity NPC210437
0.7667 Intermediate Similarity NPC106295
0.7667 Intermediate Similarity NPC51957
0.7667 Intermediate Similarity NPC16107
0.7663 Intermediate Similarity NPC99659
0.7663 Intermediate Similarity NPC325871
0.7644 Intermediate Similarity NPC19520
0.7644 Intermediate Similarity NPC149090
0.7637 Intermediate Similarity NPC88249
0.7637 Intermediate Similarity NPC192768
0.7637 Intermediate Similarity NPC151895

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC254581 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.914 High Similarity NPD8095 Phase 1
0.8901 High Similarity NPD8054 Approved
0.8901 High Similarity NPD8053 Approved
0.8722 High Similarity NPD8251 Approved
0.8722 High Similarity NPD8252 Approved
0.8722 High Similarity NPD8099 Discontinued
0.8674 High Similarity NPD8156 Discontinued
0.8095 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7713 Intermediate Similarity NPD4010 Discontinued
0.7667 Intermediate Similarity NPD4584 Approved
0.7634 Intermediate Similarity NPD6788 Approved
0.7525 Intermediate Similarity NPD7906 Approved
0.7433 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD4773 Phase 2
0.7419 Intermediate Similarity NPD4772 Phase 2
0.7407 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD7833 Phase 2
0.7407 Intermediate Similarity NPD7831 Phase 2
0.7389 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD7298 Approved
0.7344 Intermediate Similarity NPD6071 Discontinued
0.7333 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7310 Approved
0.7323 Intermediate Similarity NPD7311 Approved
0.7323 Intermediate Similarity NPD7313 Approved
0.7323 Intermediate Similarity NPD7312 Approved
0.7286 Intermediate Similarity NPD7309 Approved
0.7254 Intermediate Similarity NPD3051 Approved
0.7236 Intermediate Similarity NPD4577 Approved
0.7236 Intermediate Similarity NPD4578 Approved
0.7219 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD2969 Approved
0.7216 Intermediate Similarity NPD2970 Approved
0.7214 Intermediate Similarity NPD4663 Approved
0.7189 Intermediate Similarity NPD7447 Phase 1
0.7186 Intermediate Similarity NPD7549 Discontinued
0.7179 Intermediate Similarity NPD2489 Approved
0.7179 Intermediate Similarity NPD27 Approved
0.715 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD2563 Approved
0.712 Intermediate Similarity NPD2560 Approved
0.7047 Intermediate Similarity NPD4055 Discovery
0.7043 Intermediate Similarity NPD7213 Phase 3
0.7043 Intermediate Similarity NPD7212 Phase 2
0.7043 Intermediate Similarity NPD2420 Approved
0.7043 Intermediate Similarity NPD2421 Approved
0.7041 Intermediate Similarity NPD6688 Approved
0.7041 Intermediate Similarity NPD6687 Approved
0.7027 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD1424 Approved
0.7005 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD2898 Approved
0.7 Intermediate Similarity NPD4675 Approved
0.7 Intermediate Similarity NPD4678 Approved
0.6995 Remote Similarity NPD4581 Clinical (unspecified phase)
0.6978 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6978 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6974 Remote Similarity NPD5677 Discontinued
0.6931 Remote Similarity NPD6030 Approved
0.6931 Remote Similarity NPD6031 Approved
0.6919 Remote Similarity NPD4481 Phase 3
0.6907 Remote Similarity NPD8153 Approved
0.6907 Remote Similarity NPD8152 Approved
0.6898 Remote Similarity NPD3845 Phase 1
0.6898 Remote Similarity NPD7124 Phase 2
0.6887 Remote Similarity NPD3450 Approved
0.6887 Remote Similarity NPD2494 Approved
0.6887 Remote Similarity NPD2493 Approved
0.6887 Remote Similarity NPD3452 Approved
0.6878 Remote Similarity NPD6090 Discontinued
0.6862 Remote Similarity NPD7598 Phase 2
0.6859 Remote Similarity NPD4017 Approved
0.6857 Remote Similarity NPD2975 Approved
0.6857 Remote Similarity NPD2973 Approved
0.6857 Remote Similarity NPD2974 Approved
0.6853 Remote Similarity NPD7802 Discontinued
0.6853 Remote Similarity NPD6107 Approved
0.6845 Remote Similarity NPD5241 Discontinued
0.6842 Remote Similarity NPD2122 Discontinued
0.6842 Remote Similarity NPD3641 Approved
0.6842 Remote Similarity NPD3640 Phase 3
0.6842 Remote Similarity NPD3639 Approved
0.684 Remote Similarity NPD7501 Clinical (unspecified phase)
0.683 Remote Similarity NPD6997 Phase 2
0.6816 Remote Similarity NPD42 Phase 2
0.6816 Remote Similarity NPD6042 Phase 2
0.6804 Remote Similarity NPD5773 Approved
0.6804 Remote Similarity NPD5772 Approved
0.6796 Remote Similarity NPD4474 Approved
0.6796 Remote Similarity NPD4475 Approved
0.6792 Remote Similarity NPD3837 Clinical (unspecified phase)
0.6791 Remote Similarity NPD4583 Approved
0.6791 Remote Similarity NPD4582 Approved
0.6788 Remote Similarity NPD6072 Discontinued
0.6787 Remote Similarity NPD7047 Phase 3
0.6786 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6779 Remote Similarity NPD2488 Approved
0.6779 Remote Similarity NPD2490 Approved
0.6776 Remote Similarity NPD5006 Approved
0.6776 Remote Similarity NPD5005 Approved
0.6771 Remote Similarity NPD4005 Discontinued
0.6761 Remote Similarity NPD4580 Approved
0.6744 Remote Similarity NPD4002 Approved
0.6744 Remote Similarity NPD4004 Approved
0.6738 Remote Similarity NPD5177 Phase 3
0.6737 Remote Similarity NPD4123 Phase 3
0.6702 Remote Similarity NPD6748 Discontinued
0.6699 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6684 Remote Similarity NPD6523 Clinical (unspecified phase)
0.6684 Remote Similarity NPD3124 Discontinued
0.6667 Remote Similarity NPD6996 Clinical (unspecified phase)
0.665 Remote Similarity NPD5312 Approved
0.665 Remote Similarity NPD2971 Approved
0.665 Remote Similarity NPD5313 Approved
0.665 Remote Similarity NPD2968 Approved
0.665 Remote Similarity NPD3337 Discontinued
0.6649 Remote Similarity NPD2200 Suspended
0.6648 Remote Similarity NPD5718 Phase 2
0.6648 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6636 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6633 Remote Similarity NPD7046 Clinical (unspecified phase)
0.6632 Remote Similarity NPD6666 Approved
0.6632 Remote Similarity NPD6667 Approved
0.663 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6621 Remote Similarity NPD7671 Approved
0.6621 Remote Similarity NPD7672 Approved
0.662 Remote Similarity NPD6621 Clinical (unspecified phase)
0.6618 Remote Similarity NPD6853 Approved
0.6618 Remote Similarity NPD6851 Approved
0.6615 Remote Similarity NPD2183 Approved
0.6615 Remote Similarity NPD2184 Approved
0.6614 Remote Similarity NPD7466 Approved
0.6602 Remote Similarity NPD7132 Clinical (unspecified phase)
0.6598 Remote Similarity NPD8158 Clinical (unspecified phase)
0.6596 Remote Similarity NPD7045 Clinical (unspecified phase)
0.6589 Remote Similarity NPD4420 Approved
0.6585 Remote Similarity NPD6297 Approved
0.6582 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6579 Remote Similarity NPD3692 Discontinued
0.6577 Remote Similarity NPD7827 Phase 1
0.6559 Remote Similarity NPD7718 Clinical (unspecified phase)
0.6552 Remote Similarity NPD5602 Clinical (unspecified phase)
0.6545 Remote Similarity NPD2422 Clinical (unspecified phase)
0.6544 Remote Similarity NPD7590 Clinical (unspecified phase)
0.6538 Remote Similarity NPD4908 Phase 1
0.6538 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6537 Remote Similarity NPD7479 Phase 2
0.6535 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6522 Remote Similarity NPD4419 Clinical (unspecified phase)
0.652 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6508 Remote Similarity NPD7037 Approved
0.6503 Remote Similarity NPD4625 Phase 3
0.65 Remote Similarity NPD8398 Clinical (unspecified phase)
0.65 Remote Similarity NPD5709 Phase 3
0.6495 Remote Similarity NPD5976 Discontinued
0.6492 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7907 Approved
0.649 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6489 Remote Similarity NPD1632 Clinical (unspecified phase)
0.6488 Remote Similarity NPD4873 Discontinued
0.6486 Remote Similarity NPD1613 Approved
0.6486 Remote Similarity NPD2238 Phase 2
0.6486 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6485 Remote Similarity NPD4166 Phase 2
0.6484 Remote Similarity NPD4040 Phase 1
0.6484 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6477 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6474 Remote Similarity NPD4236 Phase 3
0.6474 Remote Similarity NPD3060 Approved
0.6474 Remote Similarity NPD4237 Approved
0.6471 Remote Similarity NPD6895 Approved
0.6471 Remote Similarity NPD6896 Approved
0.6471 Remote Similarity NPD6111 Discontinued
0.6471 Remote Similarity NPD5938 Phase 3
0.6468 Remote Similarity NPD4666 Phase 3
0.6467 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6465 Remote Similarity NPD4585 Approved
0.6465 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6458 Remote Similarity NPD6783 Clinical (unspecified phase)
0.645 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6447 Remote Similarity NPD5090 Approved
0.6447 Remote Similarity NPD5089 Approved
0.6447 Remote Similarity NPD7438 Suspended
0.6445 Remote Similarity NPD7291 Discontinued
0.6443 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6439 Remote Similarity NPD7177 Discontinued
0.6436 Remote Similarity NPD1753 Discontinued
0.6413 Remote Similarity NPD2669 Clinical (unspecified phase)
0.641 Remote Similarity NPD7427 Discontinued
0.6408 Remote Similarity NPD5844 Phase 1
0.6406 Remote Similarity NPD2677 Approved
0.6402 Remote Similarity NPD7125 Discontinued
0.64 Remote Similarity NPD7773 Phase 2
0.6396 Remote Similarity NPD7701 Phase 2
0.6392 Remote Similarity NPD7020 Approved
0.6392 Remote Similarity NPD7019 Approved
0.6387 Remote Similarity NPD4162 Approved
0.6386 Remote Similarity NPD2904 Discontinued
0.6385 Remote Similarity NPD6656 Clinical (unspecified phase)
0.6385 Remote Similarity NPD5525 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data